Cancer Treatment Kills Tumors by 'Cooking'
A radically new approach attacks remote tumors once unreachable with surgery.
CLEVELAND, Feb. 19, 2009— -- Ruth Perko is one of at least 97,000 Americans diagnosed with a malignant brain tumor each year, according to the National Cancer Institute, and nothing can prepare her for the experimental treatment she's about to receive.
Perko, like so many patients, has already had surgery, radiation and chemotherapy, but the tumor inside her brain has grown back.
So the 51-year-old mother of three will now try something radically different. Doctors will attack the tumor by "cooking" it.
WATCH "World News with Charles Gibson" TONIGHT at 6:30 p.m. E.T. for the full report.
For the next 12 hours, Perko will be kept unconscious at the Cleveland Clinic in Cleveland, Ohio. Working through a half-inch opening in her skull, doctors insert a fiber-optic laser "probe" all the way down to the base of her skull.
The newly-developed probe can reach areas difficult -- if not impossible -- to reach through conventional surgery. It's one of the many recent advances in a technique first attempted a decade ago.
"This allows us to steer the laser in different directions," said Dr. Gene Barnett, director of the Brain Tumor and Neuro Oncology Center at the Cleveland Clinic. In addition, Barnett said the new probe can "protect normal brain, thereby bringing the benefits of surgery to patients who otherwise had inoperable brain tumors."
With the probe now inside Perko's brain tumor, doctors fire the laser. Each burst lasts anywhere from 30 seconds to a few minutes and generates up to 160 degrees (Fahrenheit) of heat, enough to restrict blood flow to the area and kill the cancer cells. Doctors carefully monitor the temperature by keeping Perko in an MRI machine throughout the procedure.
"We can monitor the temperature rise in the tumor, second by second, while we're scanning the patient," said Dr. Stephen Jones, a neuro radiologist at the Cleveland Clinic. "Better than that," he said, "we can see the predictive margins of response where we are killing the tumor... where the cancer cells are dying."